Skip header and navigation

Narrow By

47 records – page 1 of 3.

About the Baby-Friendly Initiative and Infant Feeding Policy

https://libcat.nshealth.ca/en/permalink/chpams38215
Nova Scotia Health Authority. South Shore Regional Hospital. Women and Children Health Services. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2365
Available Online
View Pamphlet
The Baby-Friendly Initiative (BFI) is an international program created to support parents, babies, and families by supporting families to make an informed decision about how they feed their baby, promoting practices that give parents and babies a healthy start, and protecting families from marketing pressures. All hospitals and public health units in Nova Scotia Health are working towards becoming designated as Baby-Friendly. The IWK became designated in 2019. This pamphlet explains what staff …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. South Shore Regional Hospital. Women and Children Health Services
Alternate Title
About the BFI and IFP
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Infant
Nutrition
Breast Feeding
Subjects (LCSH)
Infants--Nutrition
Breastfeeding
Specialty
Gynecology
Abstract
The Baby-Friendly Initiative (BFI) is an international program created to support parents, babies, and families by supporting families to make an informed decision about how they feed their baby, promoting practices that give parents and babies a healthy start, and protecting families from marketing pressures. All hospitals and public health units in Nova Scotia Health are working towards becoming designated as Baby-Friendly. The IWK became designated in 2019. This pamphlet explains what staff at a Baby-Friendly facility will help you to do. It also gives information about Nova Scotia Health and IWK Health's Infant Feeding Policy. A link for more information is included.
Responsibility
Prepared by: Women and Children Health Services, South Shore Regional Hospital
Pamphlet Number
2365
Less detail

After vulvar biopsy or excision

https://libcat.nshealth.ca/en/permalink/chpams35624
Nova Scotia Health Authority. Central Zone. Gynecolposcopy Clinic. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1625
Available Online
View Pamphlet
This sheet provides general skin care instructions for after a vulvar biopsy or vulvar excision.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Gynecolposcopy Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([1] p.) : digital, PDF file
Subjects (MeSH)
Vulvar Neoplasms - diagnosis
Vulvar Diseases - diagnosis
Subjects (LCSH)
Vulva--Diseases
Specialty
Gynecology
Abstract
This sheet provides general skin care instructions for after a vulvar biopsy or vulvar excision.
Responsibility
Prepared by: Gynecolposcopy Clinic
Pamphlet Number
1625
Less detail

After your procedure

https://libcat.nshealth.ca/en/permalink/chpams35427
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1509
Available Online
View Pamphlet
Instructions for after your abortion are given, including a list of activities to avoid for 24 hours (1 day). A list of symptoms that require medical attention is provided. Information on preventing infection, what to expect after you go home, and who to contact if you have questions is given. A link to a feedback survey and contact information for free counselling is provided. The French version of this pamphlet 2109, "Après votre intervention", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Alternate Title
After your abortion
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([6] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Abortion
Pregnancy, Unwanted
Specialty
Gynecology
Abstract
Instructions for after your abortion are given, including a list of activities to avoid for 24 hours (1 day). A list of symptoms that require medical attention is provided. Information on preventing infection, what to expect after you go home, and who to contact if you have questions is given. A link to a feedback survey and contact information for free counselling is provided. The French version of this pamphlet 2109, "Après votre intervention", is also available.
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1509
Less detail

Après votre intervention

https://libcat.nshealth.ca/en/permalink/chpams36741
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2109
Available Online
View Pamphlet
Le dépliant fournit des instructions à suivre après votre avortement, dont une liste des choses à éviter pendant 24 heures (une journée). Vous y trouverez une liste des symptômes qui exigent des soins médicaux, ainsi que de l’information sur la prévention de l’infection, le retour à la maison et les personnes à joindre si vous avez des questions. On vous propose un lien vers un questionnaire de rétroaction et les coordonnées pour obtenir du counseling gratuit. ; This pamphlet is a French transl…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Alternate Title
Après votre avortement
After your procedure
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([6] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Abortion
Pregnancy, Unwanted
Specialty
Gynecology
Abstract
Le dépliant fournit des instructions à suivre après votre avortement, dont une liste des choses à éviter pendant 24 heures (une journée). Vous y trouverez une liste des symptômes qui exigent des soins médicaux, ainsi que de l’information sur la prévention de l’infection, le retour à la maison et les personnes à joindre si vous avez des questions. On vous propose un lien vers un questionnaire de rétroaction et les coordonnées pour obtenir du counseling gratuit.
This pamphlet is a French translation of "After Your Procedure" pamphlet 1509. Instructions for after your abortion are given, including a list of activities to avoid for 24 hours (1 day). A list of symptoms that require medical attention is provided. Information on preventing infection, what to expect after you go home, and who to contact if you have questions is given. A link to a feedback survey and contact information for free counselling is provided.
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
2109
Less detail

Avortement par instruments

https://libcat.nshealth.ca/en/permalink/chpams35931
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1862
Available Online
View Pamphlet
La présente brochure explique ce qu’est l’avortement par instruments, qui peut avoir un avortement par instruments, ce qui se passe durant l’intervention et les risques possibles. On y indique ce à quoi vous attendre après votre retour à la maison et qui contacter pour de plus amples renseignements. ; This pamphlet is a French translation of "Procedural Abortion" pamphlet 1832. This pamphlet explains what a procedural abortion is, who can get a procedural abortion, what happens during a procedu…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Alternate Title
Procedural abortion
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Pregnancy, Unwanted
Abortion
Specialty
Gynecology
Abstract
La présente brochure explique ce qu’est l’avortement par instruments, qui peut avoir un avortement par instruments, ce qui se passe durant l’intervention et les risques possibles. On y indique ce à quoi vous attendre après votre retour à la maison et qui contacter pour de plus amples renseignements.
This pamphlet is a French translation of "Procedural Abortion" pamphlet 1832. This pamphlet explains what a procedural abortion is, who can get a procedural abortion, what happens during a procedural abortion, and possible risks. What to expect after you go home and who to contact for further information is included.
Notes
Previous title: Avortement chirurgical
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1862
Less detail

Avortement par médicaments

https://libcat.nshealth.ca/en/permalink/chpams35925
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1861
Available Online
View Pamphlet
La présente brochure explique ce qu’est l’avortement par médicaments, qui peut avoir un avortement par médicaments, ce qui se passe durant l’intervention et les risques et effets secondaires possibles. Vous y trouverez des instructions pour prendre le médicament Mifegymiso afin de provoquer un avortement par médicaments et les coordonnées pour obtenir plus d'information. ; This pamphlet is a French translation of "Medical Abortion" pamphlet 1831. This pamphlet explains what a medical abortion i…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Alternate Title
Medical abortion
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Pregnancy, Unwanted
Abortion
Specialty
Gynecology
Abstract
La présente brochure explique ce qu’est l’avortement par médicaments, qui peut avoir un avortement par médicaments, ce qui se passe durant l’intervention et les risques et effets secondaires possibles. Vous y trouverez des instructions pour prendre le médicament Mifegymiso afin de provoquer un avortement par médicaments et les coordonnées pour obtenir plus d'information.
This pamphlet is a French translation of "Medical Abortion" pamphlet 1831. This pamphlet explains what a medical abortion is, who can get a medical abortion, what happens during a medical abortion, and possible risks and side effects. Instructions for taking the medication Mifegymiso to cause a medical abortion, and who to contact for further information are included.
Notes
Previous title: Avortement médicamenteux
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1861
Less detail

Birth control after having a baby

https://libcat.nshealth.ca/en/permalink/chpams37296
Nova Scotia Health Authority. South Shore Regional Hospital. Maternal and Child Health Services. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
2155
Available Online
View Pamphlet
This pamphlet explains the different birth control methods that can be used after having a baby. A list of resources is included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. South Shore Regional Hospital. Maternal and Child Health Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Contraception - methods
Subjects (LCSH)
Contraception
Specialty
Gynecology
Abstract
This pamphlet explains the different birth control methods that can be used after having a baby. A list of resources is included.
Responsibility
Prepared by: Maternal and Child Health Services, South Shore Regional Hospital
Pamphlet Number
2155
Less detail

Birth Control Implant

https://libcat.nshealth.ca/en/permalink/chpams38211
Nova Scotia Health Authority. QEII. ROSE Clinic. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2361
Available Online
View Pamphlet
A birth control implant is a plastic rod. It is 4 cm long and 2 mm wide. The implant goes under your skin on the inside of your upper arm between your armpit and your elbow. This pamphlet explains how the implant is put in, how the implant works and how well it works, when the implant will start working, and what will happen when the implant is removed. Benefits and side effects of the implant, things that can change how well the implant works, and if the implant will protect you from sexually …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. ROSE Clinic
Alternate Title
BCI
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Contraception - methods
Subjects (LCSH)
Contraception
Specialty
Gynecology
Abstract
A birth control implant is a plastic rod. It is 4 cm long and 2 mm wide. The implant goes under your skin on the inside of your upper arm between your armpit and your elbow. This pamphlet explains how the implant is put in, how the implant works and how well it works, when the implant will start working, and what will happen when the implant is removed. Benefits and side effects of the implant, things that can change how well the implant works, and if the implant will protect you from sexually transmitted infections (STIs) is explained. A list of situations in which you should not get the implant is included.
Responsibility
Prepared by: ROSE Clinic, QE II
Pamphlet Number
2361
Less detail

Birth control medication interaction with sugammadex (Bridion®)

https://libcat.nshealth.ca/en/permalink/chpams36680
Nova Scotia Health Authority. Department of Anesthesia. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2076
Available Online
View Pamphlet
During your surgery, you were given a medication that affects how well birth control medications work. It is important that you know this if you are on any type of hormonal contraceptive (birth control medication). Sugammadex (Bridion®) is a medication that helps you recover faster from the muscle relaxant used during your surgery. Sugammadex may lower how well your hormonal birth control works for 7 days (1 week). Use a back-up birth control method for at least 7 days after your surgery. If yo…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Department of Anesthesia
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([1] p.) : digital, PDF file
Subjects (MeSH)
Sugammadex - adverse effects
Hormonal Contraception
Subjects (LCSH)
Birth control
Sugammadex
Specialty
Gynecology
Abstract
During your surgery, you were given a medication that affects how well birth control medications work. It is important that you know this if you are on any type of hormonal contraceptive (birth control medication). Sugammadex (Bridion®) is a medication that helps you recover faster from the muscle relaxant used during your surgery. Sugammadex may lower how well your hormonal birth control works for 7 days (1 week). Use a back-up birth control method for at least 7 days after your surgery. If you are using an oral contraceptive (birth control pill), take it as usual. Types of hormonal birth control and back-up methods are listed. The French version of this pamphlet 2202, "Interaction des contraceptifs avec le sugammadex (Bridion™)", is also available.
Notes
Previous title: Birth control medication interaction with sugammadex (Bridion™)
Responsibility
Prepared by: Department of Anesthesia
Pamphlet Number
2076
Less detail

Cervical Cancer Screening : A Guide to Colposcopy

https://libcat.nshealth.ca/en/permalink/chpams37422
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
1678
Available Online
View Pamphlet
A colposcopy is an examination of the cervix using a special microscope called a colposcope. This pamphlet describes why you were referred for a colposcopy test, what will happen during the appointment, and afterward including next steps based on test results. Terms used in the guide are explained.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Colposcopy
Uterine Cervical Neoplasms - diagnosis
Subjects (LCSH)
Cervix uteri--Cancer--Diagnosis
Colposcopy
Specialty
Diagnosis
Gynecology
Abstract
A colposcopy is an examination of the cervix using a special microscope called a colposcope. This pamphlet describes why you were referred for a colposcopy test, what will happen during the appointment, and afterward including next steps based on test results. Terms used in the guide are explained.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
1678
Less detail

Cervical Cancer Screening : A Guide to Your Pap Test Results

https://libcat.nshealth.ca/en/permalink/chpams37424
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2019.
Pamphlet Number
1680
Available Online
View Pamphlet
A Pap test checks for cell changes on the cervix and is an important screening test for cervical cancer. This pamphlet explains the different results and next steps.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (2 p.) : digital, PDF file
Subjects (MeSH)
Papanicolaou Test
Uterine Cervical Neoplasms - diagnosis
Subjects (LCSH)
Cervix uteri--Cancer--Diagnosis
Pap test
Specialty
Diagnosis
Gynecology
Abstract
A Pap test checks for cell changes on the cervix and is an important screening test for cervical cancer. This pamphlet explains the different results and next steps.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Health Authority Cancer Care Program
Pamphlet Number
1680
Less detail

Cervical ripening with dinoprostone vaginal gel (Prostin)

https://libcat.nshealth.ca/en/permalink/chpams35822
Nova Scotia Health Authority. Women and Children's Health. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1772
Available Online
View Pamphlet
Prostin® is a gel. It contains medication called dinoprostone (prostaglandin E2). Dinoprostone PGE2 (or Prostin®) is like a natural substance made by your body. It softens the cervix to get it ready for labour. This pamphlet explains what to expect when you get Prostin®, possible complications of Prostin®, and when you should call or return to the hospital. The French version of this pamphlet 1817, "Maturation cervicale au moyen du gel vaginal de dinoprostone (ProstinMD)", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Health
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Cervical Ripening
Dinoprostone
Subjects (LCSH)
Labor (Obstetrics)
Specialty
Gynecology
Abstract
Prostin® is a gel. It contains medication called dinoprostone (prostaglandin E2). Dinoprostone PGE2 (or Prostin®) is like a natural substance made by your body. It softens the cervix to get it ready for labour. This pamphlet explains what to expect when you get Prostin®, possible complications of Prostin®, and when you should call or return to the hospital. The French version of this pamphlet 1817, "Maturation cervicale au moyen du gel vaginal de dinoprostone (ProstinMD)", is also available.
Responsibility
Prepared by: Women and Children's Health Unit
Pamphlet Number
1772
Less detail

Cervical Screening Practice Guidelines

https://libcat.nshealth.ca/en/permalink/chpams37421
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2019.
Pamphlet Number
1677
Available Online
View Pamphlet
Guidelines for cervical screening are explained, including who should be screened and how frequently. Those who should be screened more frequently are outlined.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (2 p.) : digital, PDF file
Subjects (MeSH)
Uterine Cervical Neoplasms - diagnosis
Subjects (LCSH)
Cervix uteri--Cancer--Diagnosis
Specialty
Diagnosis
Gynecology
Abstract
Guidelines for cervical screening are explained, including who should be screened and how frequently. Those who should be screened more frequently are outlined.
Notes
Health professional guide
Responsibility
prepared by Nova Scotia Health Authority Cancer Care Program
Pamphlet Number
1677
Less detail

Comment appliquer votre onguent stéroïde

https://libcat.nshealth.ca/en/permalink/chpams36742
Nova Scotia Health Authority. QEII. Gynecolposcopy Clinic. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
2111
Available Online
View Pamphlet
Le feuillet fournit des instructions pour l’application d’un onguent stéroïde sur la vulve pour traiter votre maladie de peau. Un diagramme est présenté pour vous indiquer exactement où appliquer l’onguent. Des conseils et des directives sont fournis. ; This pamphlet is a French translation of "How to Apply Your Steroid Ointment" pamphlet 1607. This 1-page sheet outlines instructions for applying steroid ointment to your vulva to treat your particular skin condition. A diagram is provided to sh…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Gynecolposcopy Clinic
Alternate Title
How to apply your steroid ointment
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([1] p.) : digital, PDF file
Subjects (MeSH)
Vulvar Diseases - drug therapy
Subjects (LCSH)
Vulva--Diseases
Specialty
Gynecology
Abstract
Le feuillet fournit des instructions pour l’application d’un onguent stéroïde sur la vulve pour traiter votre maladie de peau. Un diagramme est présenté pour vous indiquer exactement où appliquer l’onguent. Des conseils et des directives sont fournis.
This pamphlet is a French translation of "How to Apply Your Steroid Ointment" pamphlet 1607. This 1-page sheet outlines instructions for applying steroid ointment to your vulva to treat your particular skin condition. A diagram is provided to show you exactly where to apply the ointment. Tips to remember and special instructions are given.
Responsibility
Prepared by: Gynecolposcopy Clinic
Pamphlet Number
2111
Less detail

Déclenchement artificiel du travail

https://libcat.nshealth.ca/en/permalink/chpams35877
Nova Scotia Health Authority. Women and Children's Health Unit. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1813
Available Online
View Pamphlet
On parle de déclenchement artificiel du travail quand une méthode ou un médicament est utilisé pour commencer le travail avant qu’il ne commence par lui-même. Le but du déclenchement artificiel du travail est l’accouchement vaginal. Le présent dépliant explique pourquoi on vous offre le déclenchement artificiel du travail, la façon dont il est fait, le temps nécessaire et ce qui se passe à votre arrivée à l’hôpital. On traite aussi de ce qu’il faut faire si le déclenchement artificiel du travai…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Health Unit
Alternate Title
Induction of labour
Induction of labor
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Subjects (LCSH)
Labor (Obstetrics)
Specialty
Gynecology
Abstract
On parle de déclenchement artificiel du travail quand une méthode ou un médicament est utilisé pour commencer le travail avant qu’il ne commence par lui-même. Le but du déclenchement artificiel du travail est l’accouchement vaginal. Le présent dépliant explique pourquoi on vous offre le déclenchement artificiel du travail, la façon dont il est fait, le temps nécessaire et ce qui se passe à votre arrivée à l’hôpital. On traite aussi de ce qu’il faut faire si le déclenchement artificiel du travail est reporté.
This pamphlet is a French translation of "Induction of labour" pamphlet 1813. Induction of labour is when a method or medication is used to start labour before it starts on its own. The goal of induction is to have a vaginal birth. This pamphlet explains why you are being offered induction, how it is done, how long it takes, and what will happen when you come to the hospital. What to do if your induction is postponed is also discussed.
Responsibility
Prepared by: Women and Children's Health Unit
Pamphlet Number
1813
Less detail

Déclenchement artificiel du travail et maturation cervicale au moyen de comprimés oraux de misoprostol (prostaglandine E1) (Cytotec)

https://libcat.nshealth.ca/en/permalink/chpams35880
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1816
Available Online
View Pamphlet
Le misoprostol est une pilule qui contient un médicament appelé prostaglandine E1. La prostaglandine E1 assouplit le col de l’utérus pour le préparer au travail et déclencher des contractions. Cytotec® est le nom de marque de ce médicament. Le présent dépliant explique à quoi s'attendre si vous prenez du misoprostol, les complications possibles et quand informer un membre de votre équipe de soins de santé. ; This pamphlet is a French translation of "Induction of Labour and Cervical Ripening wit…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit
Alternate Title
Induction of labour and cervical ripening with oral misoprostol (prostaglandin E1) (Cytotec®)
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Cervical Ripening
Misoprostol
Subjects (LCSH)
Labor (Obstetrics)
Specialty
Gynecology
Abstract
Le misoprostol est une pilule qui contient un médicament appelé prostaglandine E1. La prostaglandine E1 assouplit le col de l’utérus pour le préparer au travail et déclencher des contractions. Cytotec® est le nom de marque de ce médicament. Le présent dépliant explique à quoi s'attendre si vous prenez du misoprostol, les complications possibles et quand informer un membre de votre équipe de soins de santé.
This pamphlet is a French translation of "Induction of Labour and Cervical Ripening with Oral Misoprostol (Prostaglandin E1) (Cytotec®)" pamphlet 1771. Misoprostol is a pill that contains a medication called prostaglandin E1. Prostaglandin E1 softens the cervix to get it ready for labour and to cause labour contractions. Cytotec® is the brand name of this medication. This pamphlet explains what to expect when you get misoprostol, possible complications of misoprostol, and when you should notify a member of your health care team.
Responsibility
Prepared by: Women and Children's Health Unit
Pamphlet Number
1816
Less detail

Déclenchement artificiel du travail et maturation cervicale au moyen d’un cathéter à ballonnet

https://libcat.nshealth.ca/en/permalink/chpams35878
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1814
Available Online
View Pamphlet
Un cathéter à ballonnet est un tube souple muni d’un petit ballonnet à l’extrémité. Le cathéter à ballonnet aide à préparer le col de votre utérus pour le travail (maturation cervicale ou du col). Le présent dépliant explique ce qui se passe quand le cathéter à ballonnet est inséré (mis en place), les complications possibles et quand appeler l’hôpital ou y revenir. ; This pamphlet is a French translation of "Induction of labour and cervical ripening with balloon catheter" pamphlet 1769. A ballo…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit
Alternate Title
Induction of labour and cervical ripening with balloon catheter
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Cervical Ripening
Catheters
Subjects (LCSH)
Labor (Obstetrics)
Catheters
Specialty
Gynecology
Abstract
Un cathéter à ballonnet est un tube souple muni d’un petit ballonnet à l’extrémité. Le cathéter à ballonnet aide à préparer le col de votre utérus pour le travail (maturation cervicale ou du col). Le présent dépliant explique ce qui se passe quand le cathéter à ballonnet est inséré (mis en place), les complications possibles et quand appeler l’hôpital ou y revenir.
This pamphlet is a French translation of "Induction of labour and cervical ripening with balloon catheter" pamphlet 1769. A balloon catheter is a soft tube with a small balloon on the end. The balloon catheter helps to get your cervix ready for labour (cervical ripening). This pamphlet explains what will happen when the balloon catheter is inserted (put in), possible complications of a balloon catheter, and when you should call or return to the hospital.
Responsibility
Prepared by: Women and Children's Health Unit
Pamphlet Number
1814
Less detail

Déclenchement artificiel du travail et maturation cervicale au moyen d’une insertion vaginale de dinoprostone (Cervidil)

https://libcat.nshealth.ca/en/permalink/chpams35879
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1815
Available Online
View Pamphlet
Cervidil® est un dispositif mince et plat, comme un tampon. Il contient un médicament appelé dinoprostone. La dinoprostone est comme une substance naturelle produite par votre corps. Elle assouplit le col de votre utérus pour le préparer au travail. Le présent dépliant explique à quoi vous attendre comme suite à l’utilisation d’une insertion vaginale Cervidil®, les complications possibles et quand appeler l’hôpital ou y retourner. ; This pamphlet is a French translation of "Induction of Labour …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit
Alternate Title
Induction of labour and cervical ripening with Dinoprostone vaginal insert (Cervidil®)
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Cervical Ripening
Dinoprostone
Subjects (LCSH)
Labor (Obstetrics)
Specialty
Gynecology
Abstract
Cervidil® est un dispositif mince et plat, comme un tampon. Il contient un médicament appelé dinoprostone. La dinoprostone est comme une substance naturelle produite par votre corps. Elle assouplit le col de votre utérus pour le préparer au travail. Le présent dépliant explique à quoi vous attendre comme suite à l’utilisation d’une insertion vaginale Cervidil®, les complications possibles et quand appeler l’hôpital ou y retourner.
This pamphlet is a French translation of "Induction of Labour and Cervical Ripening with Dinoprostone Vaginal Insert (Cervidil®)" pamphlet 1770. Cervidil® is a thin, flat insert, like a tampon. It contains medication called dinoprostone. Dinoprostone is like a natural substance made by your body. It softens your cervix to get it ready for labour. This pamphlet explains what to expect when you get Cervidil®, possible complications of Cervidil®, and when you should call or return to the hospital.
Responsibility
Prepared by: Women and Children's Health Unit
Pamphlet Number
1815
Less detail

Deuxième nuit du bébé

https://libcat.nshealth.ca/en/permalink/chpams36535
Nova Scotia Health Authority. Maternal Child Provincial Policy Working Group. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1965
Available Online
View Pamphlet
La présente ressource explique les défis auxquels vous pourriez faire face 24 heures après la naissance de votre bébé. Des moyens d’apaiser votre bébé vous sont présentés. Au fur et à mesure que vous apprendrez à connaître les comportements de votre bébé, vous constaterez que c’est au sein, bien blotti contre vous, qu’il se sent le plus réconforté. ; This is a French translation of the English pamphlet 1931, “Baby's Second Night”. This pamphlet explains the challenges you may experience 24 hour…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Maternal Child Provincial Policy Working Group
Alternate Title
Baby's second night
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Breast Feeding
Infant, Newborn - growth & development
Kangaroo-Mother Care Method
Subjects (LCSH)
Breastfeeding
Newborn Infants
Specialty
Gynecology
Abstract
La présente ressource explique les défis auxquels vous pourriez faire face 24 heures après la naissance de votre bébé. Des moyens d’apaiser votre bébé vous sont présentés. Au fur et à mesure que vous apprendrez à connaître les comportements de votre bébé, vous constaterez que c’est au sein, bien blotti contre vous, qu’il se sent le plus réconforté.
This is a French translation of the English pamphlet 1931, “Baby's Second Night”. This pamphlet explains the challenges you may experience 24 hours after your baby is born. Ways to comfort your baby are provided. As you get to know your baby's behaviours, you will begin to see that they are most comforted by snuggling up to you at your breast/chest.
Responsibility
Prepared by: Maternal Child Provincial Policy Working Group with permission from Jan Barger RN, MA, IBCLC/Lactation Education Consultans; BFI Coordinator
Pamphlet Number
1965
Less detail

Eye infections in newborns caused by gonorrhea and chlamydia

https://libcat.nshealth.ca/en/permalink/chpams36641
Nova Scotia Health Authority. Women and Children’s Provincial Policy Working Group. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2050
Available Online
View Pamphlet
Gonorrhea (“gah-nuh-REE-uh”) and chlamydia (“kluh-MID-ee-uh”) are common sexually transmitted infections (STIs). Gonorrhea and chlamydia are caused by bacteria. The bacteria can be passed from an infected pregnant person to their baby during birth. Gonorrhea and chlamydia can both cause eye infections in newborns. Newborn eye infections caused by gonorrhea and chlamydia are rare, but they are serious. They must be treated quickly to avoid long-term complications. This pamphlet explains how you …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children’s Provincial Policy Working Group
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Ophthalmia Neonatorum - prevention & control
Subjects (LCSH)
Conjunctivitis, Infantile
Specialty
Gynecology
Abstract
Gonorrhea (“gah-nuh-REE-uh”) and chlamydia (“kluh-MID-ee-uh”) are common sexually transmitted infections (STIs). Gonorrhea and chlamydia are caused by bacteria. The bacteria can be passed from an infected pregnant person to their baby during birth. Gonorrhea and chlamydia can both cause eye infections in newborns. Newborn eye infections caused by gonorrhea and chlamydia are rare, but they are serious. They must be treated quickly to avoid long-term complications. This pamphlet explains how you can prevent your newborn from getting an eye infection caused by gonorrhea or chlamydia, how to know if your baby has an eye infection, and what to do if you think your newborn may have an eye infection. Resources for more information are included.
Responsibility
Prepared by: Women and Children’s Provincial Policy Working Group
Pamphlet Number
2050
Less detail

47 records – page 1 of 3.